Scarica l'app Stockscreener
17.54
3.36%
-0.61
Dopo l'orario di chiusura:
17.54
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$18.15
Aprire:
$18.13
Volume 24 ore:
1.31M
Relative Volume:
1.00
Capitalizzazione di mercato:
$865.88M
Reddito:
$224.45M
Utile/perdita netta:
$-95.27M
Rapporto P/E:
-9.0881
EPS:
-1.93
Flusso di cassa netto:
$-43.74M
1 W Prestazione:
-8.41%
1M Prestazione:
-25.68%
6M Prestazione:
-5.14%
1 anno Prestazione:
-24.46%
Intervallo 1D:
$17.43
$18.27
Intervallo di 1 settimana:
$17.43
$19.34
Portata 52W:
$13.50
$30.81
Staar Surgical Co Stock (STAA) Company Profile
Nome
Staar Surgical Co
Settore
Industria
Telefono
(626) 303-7902
Indirizzo
1911 WALKER AVE, MONROVIA, CA
Confronta STAA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
17.54 | 895.99M | 224.45M | -95.27M | -43.74M | -1.93 |
|
ISRG
Intuitive Surgical Inc
|
478.49 | 169.76B | 10.06B | 2.88B | 2.27B | 7.8807 |
|
BDX
Becton Dickinson Co
|
207.87 | 58.83B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.06 | 37.98B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
263.03 | 36.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
44.97 | 37.22B | 27.43B | 1.27B | 1.01B | 1.5829 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-16 | Ripresa | Morgan Stanley | Underweight |
| 2025-04-21 | Iniziato | Wells Fargo | Equal Weight |
| 2025-02-12 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-02-12 | Downgrade | Jefferies | Buy → Hold |
| 2025-02-12 | Downgrade | Mizuho | Outperform → Neutral |
| 2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-03-11 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-05 | Downgrade | Needham | Buy → Hold |
| 2023-12-04 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-09-15 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-08-03 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | Iniziato | Piper Sandler | Neutral |
| 2023-02-06 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-12-28 | Reiterato | BTIG Research | Buy |
| 2022-12-08 | Iniziato | Stifel | Hold |
| 2022-11-07 | Aggiornamento | Sidoti | Neutral → Buy |
| 2022-10-14 | Ripresa | Stephens | Overweight |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-04-08 | Iniziato | Needham | Buy |
| 2022-03-28 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2022-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2021-07-09 | Iniziato | Oppenheimer | Perform |
| 2021-01-19 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-10-26 | Downgrade | Sidoti | Buy → Neutral |
| 2020-08-31 | Aggiornamento | Sidoti | Neutral → Buy |
| 2020-08-06 | Reiterato | The Benchmark Company | Buy |
| 2020-07-06 | Downgrade | Sidoti | Buy → Neutral |
| 2020-06-24 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-06-15 | Iniziato | Jefferies | Buy |
| 2019-12-04 | Iniziato | BTIG Research | Buy |
| 2018-09-24 | Reiterato | The Benchmark Company | Buy |
| 2018-08-06 | Ripresa | The Benchmark Company | Buy |
| 2017-11-20 | Reiterato | The Benchmark Company | Buy |
| 2017-08-14 | Reiterato | The Benchmark Company | Buy |
| 2017-03-03 | Reiterato | The Benchmark Company | Buy |
| 2016-05-18 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2013-09-10 | Ripresa | The Benchmark Company | Buy |
| 2013-02-28 | Reiterato | The Benchmark Company | Buy |
| 2012-11-01 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | Iniziato | Northland Securities | Outperform |
| 2011-10-25 | Reiterato | The Benchmark Company | Buy |
| 2010-10-12 | Iniziato | Morgan Joseph | Buy |
| 2010-05-11 | Iniziato | Benchmark | Buy |
Mostra tutto
Staar Surgical Co Borsa (STAA) Ultime notizie
STAAR Surgical Company (STAA): A Bull Case Theory - Finviz
Staar Surgical initiated with a Neutral at Wedbush - TipRanks
STAAR Surgical sinks as it plans to terminate sale to Alcon (update) - MSN
STAA Receives Neutral Rating as Wedbush Initiates Coverage | STA - GuruFocus
STAAR names interim co-CEOs amid search for permanent leader - MedTech Dive
Staar Surgical (STAA) to Report Q4 Results: Wall Street Expects Earnings Growth - Yahoo Finance
STAAR Surgical (NASDAQ:STAA) Now Covered by Wedbush - MarketBeat
STAAR Surgical (STAA) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
STAAR Surgical Names Warren Foust and Deborah Andrews Interim Co-CEOs - VisionMonday.com
Why STAAR Surgical (STAA) stock is trading lower today - MSN
Staar Surgical names interim co-CEOs in leadership shift following failed Alcon deal - MassDevice
Why STAAR Surgical (STAA) Shares Are Down Today - bitget.com
Why STAAR Surgical (STAA) Stock Is Trading Lower Today - Finviz
Staar Surgical Appoints Interim Co-CEOs - Orange County Business Journal
STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs - pharmiweb.com
New weekly contact lens offers Canadians 16 hours of daily comfort - Stock Titan
Staar Surgical appoints Warren Foust & Deborah Andrews interim co-CEOs - marketscreener.com
STAAR Surgical Company Announces Interim Co-CEO Appointments, Effective February 1, 2026 - marketscreener.com
Staar Surgical (STAA) Appoints Interim Co-CEOs as CEO Search Beg - GuruFocus
A month after Alcon deal fell through, Staar Surgical searches for next CEO and names interim leaders - Fierce Biotech
Staar Surgical Names Interim Co-CEOs Amid Leadership Transition - TipRanks
Staar Surgical appoints COO Warren Foust, CFO Deborah Andrews as interim co-CEOs - TipRanks
STAAR Surgical Company (STAA) Stock Analysis: Insights Into The 23.34% Potential Upside - DirectorsTalk Interviews
Alcon Targets Faster Growth In 2026 With New Cataract Surgery Systems - Benzinga
Assessing Staar Surgical: Insights From 4 Financial Analysts - Benzinga
Jefferies Lowers Staar Surgical (STAA) Price Target to $21.50 | STAA Stock News - GuruFocus
Jefferies Financial Group Lowers STAAR Surgical (NASDAQ:STAA) Price Target to $21.50 - MarketBeat
Alcon announces purchase of STARR Surgical for $1.5 billion - MSN
The Truth About STAAR Surgical Co: The Tiny Eye Stock Chasing a Massive Glow-Up - AD HOC NEWS
Analysts Question STAAR Surgical Company (STAA)’s Post-Merger Standalone Valuation - Insider Monkey
The Truth About STAAR Surgical Co: Is This Eye Tech Stock About To Blow Up Or Black Out? - AD HOC NEWS
Is STAAR Surgical (STAA) Attractively Priced After Prolonged Share Price Weakness? - simplywall.st
Staar Surgical, Dynatrace, and More Stocks See Action From Activist Investors -- Barrons.com - 富途牛牛
STAAR Surgical Company (STAA) Investor Outlook: Assessing The 21% Potential Upside - DirectorsTalk Interviews
Eye-care giant Alcon spends $750M buying back its own stock - Stock Titan
Staar Surgical Terminates $1.6B Sale to Alcon - Orange County Business Journal
Implantable Collamer Lens (ICL) Market to Reach USD 810 Million - openPR.com
Why STAAR Surgical (STAA) Is Down 5.2% After Shareholders Reject Alcon Deal And Board Power Shifts - Yahoo Finance UK
Staar Surgical (STAA) Faces Challenges Post-Merger Termination - GuruFocus
STAAR Surgical, Broadwood Partners enter cooperation pact - MSN
Midday Stock Roundup: loanDepot Jumps on Trump’s Proposed Mortgage Plan - Orange County Business Journal
Staar Surgical appoints new board chair and restructures committees By Investing.com - Investing.com Nigeria
Do Not Use - ocbj.com
Staar Surgical Company Announces Board and Committee Changes, Effective January 15, 2026 - marketscreener.com
Staar Surgical (STAA): Analyst Lowers Price Target to $22 but Ma - GuruFocus
Staar Surgical appoints new board chair and restructures committees - Investing.com
Morgan Stanley reiterates Underweight rating on STAAR Surgical stock - Investing.com
STAAR Surgical announces board changes as CEO prepares to step down - Investing.com Nigeria
Staar Surgical CEO, board chair stepping down after Alcon merger fails - MassDevice
STAAR Surgical (STAA) Board Restructures Amidst Alcon Deal Colla - GuruFocus
Staar Surgical Agrees To CEO Exit After Shareholder Deal - Finimize
Staar Surgical Co Azioni (STAA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Staar Surgical Co Azioni (STAA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Jan 09 '26 |
Buy |
22.05 |
27,485 |
606,138 |
15,453,629 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Jan 06 '26 |
Buy |
21.62 |
336,946 |
7,284,281 |
15,356,437 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Jan 07 '26 |
Buy |
22.00 |
66,467 |
1,462,301 |
15,422,904 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Jan 08 '26 |
Buy |
21.94 |
3,240 |
71,082 |
15,426,144 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Nov 21 '25 |
Buy |
27.86 |
797,486 |
22,218,837 |
15,019,491 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Nov 20 '25 |
Buy |
27.14 |
393,382 |
10,675,325 |
14,222,005 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Nov 19 '25 |
Buy |
26.42 |
309,132 |
8,166,155 |
13,828,623 |
| Jiang Wei | Director |
Nov 12 '25 |
Option Exercise |
0.00 |
20,967 |
0 |
45,477 |
| Jiang Wei | Director |
Aug 12 '25 |
Option Exercise |
0.00 |
20,967 |
0 |
24,510 |
2.71%
0.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):